Year: 2016

The SEC prevailed at trial against the former CEO of a biopharmaceutical company on claims that he made false and misleading statements regarding the regulatory approval status of the firm’s only drug. Following a two week trial the jury returned …

SEC Prevails In Jury Trial Against Former CEO of Drug Firm Read More »

Tagged with: ,

Insider trading has long been a staple of SEC enforcement. The agency has brought a number of actions against corporate executives who have abused their position by using inside information entrusted to them for personal gain rather than the corporate …

SEC Settles Insider Trading Action With Corporate Executive Read More »

Tagged with: , ,